Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Validation Protocol Review and Approval – V 2.0

Posted on By

Tablets: SOP for Validation Protocol Review and Approval – V 2.0

Standard Operating Procedure for Validation Protocol Review and Approval

Department Tablet
SOP No. SOP/TAB/191/2025
Supersedes SOP/TAB/191/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

This SOP describes the process for reviewing and approving validation protocols in tablet manufacturing, ensuring that all validation activities are in compliance with regulatory standards and are conducted systematically to ensure product quality and safety.

2. Scope

This SOP applies to the review and approval of all validation protocols related to tablet manufacturing processes, including but not limited to equipment validation, cleaning validation, process validation, and computer system validation.

3. Responsibilities

  • Quality Assurance (QA): Responsible for reviewing and approving all validation protocols to ensure compliance with regulatory requirements and internal standards.
  • Validation Team: Responsible for preparing validation protocols and ensuring that they are reviewed and approved prior to the commencement of any validation activities.
  • Regulatory Affairs: Responsible for ensuring that validation protocols are aligned with applicable regulatory guidelines and requirements.
  • Production Team: Responsible for executing the validated processes and ensuring that validation activities are adhered to during production.

See also  Tablets: SOP for Lubrication of Tablet Granules - V 2.0

4. Accountability

The QA Manager is accountable for ensuring that all

validation protocols are reviewed, approved, and documented in accordance with this SOP. The Validation Team Leader is accountable for ensuring that validation protocols are accurately prepared for review and approval.

5. Procedure

5.1 Validation Protocol Preparation

  1. The Validation Team prepares a protocol for validation activities, including the objectives, scope, methodology, acceptance criteria, and timelines for each validation project.
  2. The protocol should include a risk-based approach to validation, considering the criticality of the equipment or process being validated and the potential impact on product quality.
  3. Ensure that the protocol is aligned with regulatory requirements (e.g., FDA, EMA) and internal standards.

5.2 Protocol Review

  1. The protocol should be submitted to the QA team for review. The review process should ensure that all necessary information is included and that the protocol complies with applicable guidelines and standards.
  2. QA personnel should review the protocol for clarity, completeness, and compliance with GMP and regulatory requirements.
  3. If required, the QA team may request modifications or clarifications before approving the protocol. All feedback must be documented.

5.3 Protocol Approval

  1. Once the protocol has been reviewed and any necessary changes have been made, the protocol should be formally approved by the QA Manager and the Validation Team Leader.
  2. Ensure that all approvals are documented, and the protocol is signed and dated by the individuals responsible for the review and approval.
  3. Upon approval, the protocol is considered finalized, and validation activities can proceed as per the approved protocol.
See also  Tablets: SOP for Training of Personnel in Tablet Manufacturing Areas - V 2.0

5.4 Documentation and Record Keeping

  1. All validated protocols, including reviewed and approved versions, should be retained in a secure, easily accessible location (either electronic or paper format) for a minimum of five years or as per regulatory requirements.
  2. Ensure that the validation protocol, any revisions, and related documents (e.g., change control records, validation reports) are properly filed and readily available for audit or inspection purposes.

5.5 Revision of Protocols

  1. If modifications are needed after the approval of the protocol, a revised version of the protocol must be created and reviewed following the same process outlined in this SOP.
  2. Ensure that all revisions are clearly documented with an explanation for the change and that the revised protocol is approved before implementation.

5.6 Audit and Compliance

  1. Conduct periodic audits to ensure that the validation protocols are being followed as intended and that all data generated during validation activities is compliant with regulatory and internal requirements.
  2. Document all audit findings and ensure that corrective actions are implemented for any non-compliance.

See also  Tablets: SOP for Direct Compression Blend Homogeneity Testing - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • GMP: Good Manufacturing Practice
  • FDA: Food and Drug Administration

7. Documents

  1. Validation Protocol (Annexure-1)
  2. Protocol Review and Approval Log (Annexure-2)
  3. Validation Audit Log (Annexure-3)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • ISO 9001 – Quality Management Systems
  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Validation Protocol

Protocol ID Protocol Name Prepared By Approval Date
VP-001 Equipment Validation John Doe 01/03/2026

Annexure-2: Protocol Review and Approval Log

Review Date Protocol ID Reviewer Approval Status
01/03/2026 VP-001 Jane Smith Approved

Annexure-3: Validation Audit Log

Audit Date Protocol ID Auditor Findings Corrective Actions
01/03/2026 VP-001 John Doe No discrepancies N/A

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated validation protocol approval process Clarified review procedures QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Capsule: SOP for Validation of Cleaning Procedures for Capsule Polishing Machines – V 2.0
Next Post: Capsule: SOP for Cleaning Validation for Soft Gelatin Capsule Lines – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version